978 Concordance of the FDA-approved companion diagnostic and a next-generation sequencing assay kit for assessing homologous recombination deficiency in ovarian cancer

W Weichert, P Qiu, J Lunceford, A Wehn, A Yarunin, M Marton
2021 Late breaking abstracts   unpublished
doi:10.1136/ijgc-2021-esgo.665 fatcat:6e7ztmpvhndk5bmcexanosbbkq